Gastroesophageal Reflux Disease Management

Treatment Considerations

The American Gastroenterological Association notes that the decision regarding the need for maintenance therapy (and its dosage) is driven by the impact of residual symptoms on the patient's quality of life, rather than as a means of controlling the disease 1, 2
The primary risk associated with reducing or discontinuing acid-suppressive therapy is an increase in symptom burden 1
There is no high-quality evidence to suggest that continuous anti-secretory therapy alters the natural history of reflux disease beyond reducing the already low incidence of peptic stricture 1, 3

For patients with reflux symptoms without esophageal inflammation, on-demand therapy is a reasonable strategy when symptom control is the primary goal 1, 2
It is recommended to combine pharmacological treatment with lifestyle changes, including:
- Avoiding recumbency for 2-3 hours after meals 4
- Avoiding trigger foods on an individual basis (e.g., coffee, chocolate, alcohol, spicy foods) 4
- Limiting fat intake to less than 45 grams per day as part of a reflux diet 4
- Avoiding smoking and limiting alcohol consumption 4

For extra-esophageal reflux symptoms (chronic cough, laryngitis, asthma), more intensive therapy may be required, including twice-daily proton pump inhibitors and a strict reflux diet 4
Conditions that may exacerbate reflux, such as sleep apnea, should be treated 4

The American Gastroenterological Association notes that beyond the recurrence of symptoms and/or erosive disease, the risks associated with discontinuing therapy, including the potential development of Barrett's esophagus, appear minimal 1, 3